Helga Doring

Title: Helga Doring: Innovator in Implantable Drug Delivery Systems

Introduction

Helga Doring is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of medical technology, particularly in the development of implantable drug delivery systems. Her innovative work focuses on improving treatment options for diseases affecting the bone and bone marrow.

Latest Patents

Doring holds a patent for an "Implantable drug depot and process for the production thereof." This invention is designed for the treatment of diseases of the bone or bone marrow. The implantable drug depot consists of a matrix that incorporates at least one active ingredient and contains adjuvant agents to control the kinetics of drug release. The matrix material is made from resorbable sintered calcium phosphate, composed of CaO and P.sub.2 O.sub.5 in a ratio between 5:1 and 2:1. This innovative approach aims to enhance the efficacy and safety of drug delivery in medical treatments.

Career Highlights

Helga Doring is associated with Battelle-Institut E.v., where she continues to advance her research and development efforts. Her work has garnered attention for its potential to revolutionize treatment methodologies in the medical field. Doring's dedication to innovation is evident in her patent, which reflects her commitment to improving patient outcomes.

Collaborations

Throughout her career, Doring has collaborated with notable colleagues, including Helmut Heide and Kari Koster-Losche. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Helga Doring's contributions to the field of implantable drug delivery systems highlight her role as an influential inventor. Her innovative patent demonstrates her commitment to enhancing medical treatments for bone-related diseases. Doring's work continues to inspire advancements in medical technology and patient care.